Anúncio
Anúncio

DGX

DGX logo

Quest Diagnostics Inc.

174.44
USD
Patrocinado
-3.25
-1.83%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

174.45

+0.01
+0.01%

Relatórios de Lucros DGX

Rácio de surpresa positiva

DGX separação 33 de 39 últimas estimativas.

85%

Próximo Relatório

Data do Próximo Relatório
29 de jan. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.78B
/
$2.38
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-1.25%
/
-8.46%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+6.10%
/
+2.15%

Quest Diagnostics Inc. earnings per share and revenue

On 21 de out. de 2025, DGX reported earnings of 2.60 USD per share (EPS) for Q3 25, beating the estimate of 2.52 USD, resulting in a 2.81% surprise. Revenue reached 2.82 bilhão, compared to an expected 2.76 bilhão, with a 1.89% difference. The market reacted with a -3.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of 2.38 USD, with revenue projected to reach 2.78 bilhão USD, implying an diminuir of -8.46% EPS, and diminuir of -1.25% in Revenue from the last quarter.
FAQ
For Q3 2025, Quest Diagnostics Inc. reported EPS of $2.60, beating estimates by 2.81%, and revenue of $2.82B, 1.89% above expectations.
The stock price moved down -3.03%, changed from $190.41 before the earnings release to $184.64 the day after.
The next earning report is scheduled for 29 de jan. de 2026.
Based on 18 analistas, Quest Diagnostics Inc. is expected to report EPS of $2.38 and revenue of $2.78B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio